Radioimaging of human breast carcinoma xenografts in mice by [123I]-labeled Z-17α-iodovinyl-11β-chloromethyl-estradiol

Nuclear Medicine and Biology

Volumn 23, Issue 1, 1996, Pages 69-73

  Zeicher, M ^a   Delcorde, A ^d   Quivy, J ^b,c   Dupuis, Y ^e   Vervist, A ^e   Fruhling J ^e  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b JULES BORDET INSTITUTE   (Belgium)

^c Dir Gen Technol et de la Rech   (Belgium)

^d Nouvelle Clinique de la Basilique   (Belgium)

^e NONE

Author keywords

Mice; Radioimaging; Xenografts

Indexed keywords

ESTRADIOL; IODINE 123;

ANIMAL EXPERIMENT; ARTICLE; BREAST CARCINOMA; CANCER SCINTISCANNING; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MOUSE; RADIOISOTOPE THERAPY; TUMOR XENOGRAFT;

ADENOCARCINOMA; ANIMALS; BREAST NEOPLASMS; ESTRADIOL; FEMALE; HUMANS; IODINE RADIOISOTOPES; ISOTOPE LABELING; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; OVARIECTOMY; RECEPTORS, ESTROGEN; TISSUE DISTRIBUTION;

EID: 0030069547     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/0969-8051(95)02069-1     Document Type: Article

References (13)

1. 3H]estradiol-17β: a very high affinity, reversible ligand for the estrogen receptor. J. Steroid Biochem. 28, 361-370.
2. Bloomer W. D. and Adelstein S. J. (1975) Antineoplastic effect of iodine-125 labeled iododeoxyuridine. Int. J. Radiat. Biol. 27, 509-511.
3. Cummins C. H. (1993) Radiolabeled steroidal estrogens in cancer research. Steroids 58, 245-259.
4. DeSombre E. R., Shafii B., Hanson R. N., Kuivanen P.C. and Hughes A. (1992) Estrogen receptor-directed radiotoxicity with Auger electrons: specificity and mean lethal dose. Cancer Res. 52, 5752-5758.
5. 125I] iodoestradiol in cultured MCF7 human breast cancer cells. J. Natl. Cancer Inst. 81, 437-440.
6. Quivy J., Delcorde A., Henrot P., Deblaton M., Pirotte R., Verbist A., Frühling J. and Zeicher M. (1990) New steroidal agent with high selectivity for the radioimaging of tumour tissues containing estrogen receptors. Eur. J. Nucl. Med. 16, 7, 430. Abstract.
7. Quivy J., Henrot P., Wauters M., Bastin B., Wilmotte J. M. and Deblaton M. (1994) Improvement of the tissular distribution of Z-CMIV, a high specific estrogen receptor seeking steroid by means of molecular encapsulation. In Advances in Steroid Analysis 93 (Edited by S. Görög), pp. 77-82. Akadémiai Kiado, Budapest.
8. Quivy J., Leclercq G., Deblaton M., Henrot P., Velings N., Evrard G. and Zeicher M. (1995) Z-CMIV, a high affinity ligand for in vivo targeting of ER-positive tumours: synthesis, structure analysis, and binding properties. Manuscript in preparation.
9. Quivy J. and Zeicher M. (1989) Estrane analogs as ligands for hormone-specific receptors in cancer targeting therapy and imaging applications. French Patent FR 8705524 (April 17, 1987), Eur. Patent 0,310,645 (1992), U.S. Patent 5,096,694 (1992). Chem. Abstr. 111, 187600w.
10. Raynaud J. P., Bouton M. M., Gallet-Bourquin D., Philibert D., Tournemine C. and Azadian-Boulanger G. (1973) Comparative study of estrogen action. Mol. Pharmacol. 9, 520-533.
11. Zeicher M., Henrot P., Loos M., Strijckmans P. and Quivy J. (1990) Z-11β-chloromethyl-17α-iodovinyl-estradiol, a potential agent for targeted radiotherapy of estrogen receptor positive tumors. Eur. J. Nucl. Med. 16, 7, 439. Abstract.
12. Zeicher M. and Quivy J. (1991) Radiolabeled ligands specific for estrogen and progesterone receptor and their use as diagnostic and radiotherapeutic agents and in determination of the receptors. French Patent FR 8813737 (Oct. 19 1988), Eur. Patent 0,365,421 (1992) U.S. Patent 5,002,753 (1991). Chem. Abstr. 114, 139123h.
13. 123I]iodoestradiol and its interaction with the estrogen receptor in vivo and vitro. J. Nucl. Med. 30, 209-215.